Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single Centre View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

Jayachandran Perumal Kalaiyarasi, Prasanth Ganesan, Krishnarathinam Kannan, Trivadi S. Ganesan, Venkatraman Radhakrishnan, Manikandan Dhanushkodi, S. Krupashankar, Nikita Mehra, Tenali Gnana Sagar

ABSTRACT

Background: Acute Myeloid Leukemia (AML) is a very aggressive cancer with difficult treatment and poor outcomes. The treatment of these patients is quite challenging due to various reasons including the need for extensive supportive care, and high cost of therapy. Reports on outcomes from India are few. Methods: We analyzed 93 adult patients (≥ 18 years) with AML who were treated with curative intent between 2007 and 2014. Patients received daunorubicin at dose of 60–90 mg/m2 and cytarabine 100 mg/m2 during induction and consolidation with 3 courses of high dose cytarabine (1.5–3 g/m2per dose for 6 doses per cycle). Only 4 patients underwent consolidation allogenic stem cell transplantation in first remission (CR1). Results: The median age was 37 (18–66) years; males: 52%. Conventional cytogenetics (N = 63) showed 23% (N = 15), 56% (N = 35), 27% (N = 13) in good, intermediate risk and poor risk category respectively. FLT3–ITD was positive in 12/33 (36%) and NPM mutation in 7/23 (30%). Daunorubicin dose was 60 mg/m2 in 75% (N = 70) and 90 mg/m2 in 25% (N = 23) patients. Induction mortality was 17% (16/93) [60 mg/m2:19% (13/70), and 90 mg/m2:13% (3/23); p = 0.39)]. Complete remission was achieved by 60% (56/93) [60 mg/m2:53% (37/70), and 90 mg/m2:83% (19/23); p = 0.09)]. The median overall survival was 9.2 months and the actuarial survival at 2 years was 30%. By univariate analysis, FLT3-ITD positivity, white cell counts higher than 100,000/mm3 at presentation, and use of lower dose of daunorubicin in induction were associated with poorer outcomes. Conclusions: Outcomes in adult AML are generally poor. Many patients with high risk disease don’t receive allogenic transplantation in CR1. Increased availability of allogenic stem cell transplantation may help to improve outcomes. More... »

PAGES

248-254

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12288-018-1023-0

DOI

http://dx.doi.org/10.1007/s12288-018-1023-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1107349516


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kalaiyarasi", 
        "givenName": "Jayachandran Perumal", 
        "id": "sg:person.011770565440.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011770565440.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ganesan", 
        "givenName": "Prasanth", 
        "id": "sg:person.0716343050.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716343050.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kannan", 
        "givenName": "Krishnarathinam", 
        "id": "sg:person.0657501276.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657501276.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ganesan", 
        "givenName": "Trivadi S.", 
        "id": "sg:person.01354150255.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354150255.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Radhakrishnan", 
        "givenName": "Venkatraman", 
        "id": "sg:person.010316745623.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010316745623.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dhanushkodi", 
        "givenName": "Manikandan", 
        "id": "sg:person.01225301441.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225301441.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Krupashankar", 
        "givenName": "S.", 
        "id": "sg:person.010131407614.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010131407614.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mehra", 
        "givenName": "Nikita", 
        "id": "sg:person.013004716016.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013004716016.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sagar", 
        "givenName": "Tenali Gnana", 
        "id": "sg:person.015576370407.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015576370407.55"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1182/blood-2010-07-295279", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010761932"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bjh.13406", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017282100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jhin.2016.04.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024916616"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1010222", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030828053"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1658-3876(08)50023-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031018815"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2015/710543", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031328730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-09-179341", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032016811"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.48.6886", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034141191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.47.4874", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034938389"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2015-07-657403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036230934"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0904544", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036718725"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.33.7303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036777863"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/ajco.12333", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040889000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-07-235358", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042177075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2015-01-623447", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049798638"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082058251", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "Background: Acute Myeloid Leukemia (AML) is a very aggressive cancer with difficult treatment and poor outcomes. The treatment of these patients is quite challenging due to various reasons including the need for extensive supportive care, and high cost of therapy. Reports on outcomes from India are few. Methods: We analyzed 93 adult patients (\u2265 18 years) with AML who were treated with curative intent between 2007 and 2014. Patients received daunorubicin at dose of 60\u201390 mg/m2 and cytarabine 100 mg/m2 during induction and consolidation with 3 courses of high dose cytarabine (1.5\u20133 g/m2per dose for 6 doses per cycle). Only 4 patients underwent consolidation allogenic stem cell transplantation in first remission (CR1). Results: The median age was 37 (18\u201366) years; males: 52%. Conventional cytogenetics (N = 63) showed 23% (N = 15), 56% (N = 35), 27% (N = 13) in good, intermediate risk and poor risk category respectively. FLT3\u2013ITD was positive in 12/33 (36%) and NPM mutation in 7/23 (30%). Daunorubicin dose was 60 mg/m2 in 75% (N = 70) and 90 mg/m2 in 25% (N = 23) patients. Induction mortality was 17% (16/93) [60 mg/m2:19% (13/70), and 90 mg/m2:13% (3/23); p = 0.39)]. Complete remission was achieved by 60% (56/93) [60 mg/m2:53% (37/70), and 90 mg/m2:83% (19/23); p = 0.09)]. The median overall survival was 9.2 months and the actuarial survival at 2 years was 30%. By univariate analysis, FLT3-ITD positivity, white cell counts higher than 100,000/mm3 at presentation, and use of lower dose of daunorubicin in induction were associated with poorer outcomes. Conclusions: Outcomes in adult AML are generally poor. Many patients with high risk disease don\u2019t receive allogenic transplantation in CR1. Increased availability of allogenic stem cell transplantation may help to improve outcomes.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12288-018-1023-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1107805", 
        "issn": [
          "0971-4502", 
          "0974-0449"
        ], 
        "name": "Indian Journal of Hematology and Blood Transfusion", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "35"
      }
    ], 
    "name": "Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single Centre", 
    "pagination": "248-254", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e97a72506db560a4c5b4f166648d156a3c09339337173d2b07f440eed26a17d8"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12288-018-1023-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1107349516"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12288-018-1023-0", 
      "https://app.dimensions.ai/details/publication/pub.1107349516"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78944_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs12288-018-1023-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12288-018-1023-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12288-018-1023-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12288-018-1023-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12288-018-1023-0'


 

This table displays all metadata directly associated to this object as RDF triples.

164 TRIPLES      21 PREDICATES      43 URIs      19 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12288-018-1023-0 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Na135e576e5a943d682f1500bc85594a1
4 schema:citation https://app.dimensions.ai/details/publication/pub.1082058251
5 https://doi.org/10.1016/j.jhin.2016.04.012
6 https://doi.org/10.1016/s1658-3876(08)50023-9
7 https://doi.org/10.1056/nejmoa0904544
8 https://doi.org/10.1056/nejmoa1010222
9 https://doi.org/10.1111/ajco.12333
10 https://doi.org/10.1111/bjh.13406
11 https://doi.org/10.1155/2015/710543
12 https://doi.org/10.1182/blood-2008-09-179341
13 https://doi.org/10.1182/blood-2009-07-235358
14 https://doi.org/10.1182/blood-2010-07-295279
15 https://doi.org/10.1182/blood-2015-01-623447
16 https://doi.org/10.1182/blood-2015-07-657403
17 https://doi.org/10.1200/jco.2010.33.7303
18 https://doi.org/10.1200/jco.2012.47.4874
19 https://doi.org/10.1200/jco.2013.48.6886
20 schema:datePublished 2019-04
21 schema:datePublishedReg 2019-04-01
22 schema:description Background: Acute Myeloid Leukemia (AML) is a very aggressive cancer with difficult treatment and poor outcomes. The treatment of these patients is quite challenging due to various reasons including the need for extensive supportive care, and high cost of therapy. Reports on outcomes from India are few. Methods: We analyzed 93 adult patients (≥ 18 years) with AML who were treated with curative intent between 2007 and 2014. Patients received daunorubicin at dose of 60–90 mg/m2 and cytarabine 100 mg/m2 during induction and consolidation with 3 courses of high dose cytarabine (1.5–3 g/m2per dose for 6 doses per cycle). Only 4 patients underwent consolidation allogenic stem cell transplantation in first remission (CR1). Results: The median age was 37 (18–66) years; males: 52%. Conventional cytogenetics (N = 63) showed 23% (N = 15), 56% (N = 35), 27% (N = 13) in good, intermediate risk and poor risk category respectively. FLT3–ITD was positive in 12/33 (36%) and NPM mutation in 7/23 (30%). Daunorubicin dose was 60 mg/m2 in 75% (N = 70) and 90 mg/m2 in 25% (N = 23) patients. Induction mortality was 17% (16/93) [60 mg/m2:19% (13/70), and 90 mg/m2:13% (3/23); p = 0.39)]. Complete remission was achieved by 60% (56/93) [60 mg/m2:53% (37/70), and 90 mg/m2:83% (19/23); p = 0.09)]. The median overall survival was 9.2 months and the actuarial survival at 2 years was 30%. By univariate analysis, FLT3-ITD positivity, white cell counts higher than 100,000/mm3 at presentation, and use of lower dose of daunorubicin in induction were associated with poorer outcomes. Conclusions: Outcomes in adult AML are generally poor. Many patients with high risk disease don’t receive allogenic transplantation in CR1. Increased availability of allogenic stem cell transplantation may help to improve outcomes.
23 schema:genre research_article
24 schema:inLanguage en
25 schema:isAccessibleForFree false
26 schema:isPartOf Nc4f4acd4d8164808b7ad243f2545e2ff
27 Nd57975d0721a4f72bd477b6fc5d5d69b
28 sg:journal.1107805
29 schema:name Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single Centre
30 schema:pagination 248-254
31 schema:productId N73c52f3b238a44ab9ae42a5862134930
32 Nd2d6427c171b4938a723a632e9ffb480
33 Nedbebb5b40104cbcb467258267ebd0c2
34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107349516
35 https://doi.org/10.1007/s12288-018-1023-0
36 schema:sdDatePublished 2019-04-11T13:18
37 schema:sdLicense https://scigraph.springernature.com/explorer/license/
38 schema:sdPublisher N891d62a230f9489ea544541f0cc2c606
39 schema:url https://link.springer.com/10.1007%2Fs12288-018-1023-0
40 sgo:license sg:explorer/license/
41 sgo:sdDataset articles
42 rdf:type schema:ScholarlyArticle
43 N252ea2f88c684bca9bd695e30a2c6307 rdf:first sg:person.010131407614.15
44 rdf:rest N3bbd99d554594083b64d401915bf2fba
45 N3bbd99d554594083b64d401915bf2fba rdf:first sg:person.013004716016.82
46 rdf:rest Na0de6378e1d14e81b307558d7218f51b
47 N510a6b4dccf34867b074dfa5f4c97734 rdf:first sg:person.0716343050.48
48 rdf:rest N95d8342cc14a42ea916d7394add07d13
49 N5d9d7b9daafa42d287bb8a352768a366 rdf:first sg:person.01225301441.63
50 rdf:rest N252ea2f88c684bca9bd695e30a2c6307
51 N73c52f3b238a44ab9ae42a5862134930 schema:name dimensions_id
52 schema:value pub.1107349516
53 rdf:type schema:PropertyValue
54 N83ad886b660943edabc0adbd97bdc3f9 rdf:first sg:person.010316745623.36
55 rdf:rest N5d9d7b9daafa42d287bb8a352768a366
56 N891d62a230f9489ea544541f0cc2c606 schema:name Springer Nature - SN SciGraph project
57 rdf:type schema:Organization
58 N95d8342cc14a42ea916d7394add07d13 rdf:first sg:person.0657501276.96
59 rdf:rest Nb5c3bdc26024441f861b4b15f9326e6f
60 Na0de6378e1d14e81b307558d7218f51b rdf:first sg:person.015576370407.55
61 rdf:rest rdf:nil
62 Na135e576e5a943d682f1500bc85594a1 rdf:first sg:person.011770565440.24
63 rdf:rest N510a6b4dccf34867b074dfa5f4c97734
64 Nb5c3bdc26024441f861b4b15f9326e6f rdf:first sg:person.01354150255.82
65 rdf:rest N83ad886b660943edabc0adbd97bdc3f9
66 Nc4f4acd4d8164808b7ad243f2545e2ff schema:issueNumber 2
67 rdf:type schema:PublicationIssue
68 Nd2d6427c171b4938a723a632e9ffb480 schema:name doi
69 schema:value 10.1007/s12288-018-1023-0
70 rdf:type schema:PropertyValue
71 Nd57975d0721a4f72bd477b6fc5d5d69b schema:volumeNumber 35
72 rdf:type schema:PublicationVolume
73 Nedbebb5b40104cbcb467258267ebd0c2 schema:name readcube_id
74 schema:value e97a72506db560a4c5b4f166648d156a3c09339337173d2b07f440eed26a17d8
75 rdf:type schema:PropertyValue
76 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
77 schema:name Medical and Health Sciences
78 rdf:type schema:DefinedTerm
79 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
80 schema:name Oncology and Carcinogenesis
81 rdf:type schema:DefinedTerm
82 sg:journal.1107805 schema:issn 0971-4502
83 0974-0449
84 schema:name Indian Journal of Hematology and Blood Transfusion
85 rdf:type schema:Periodical
86 sg:person.010131407614.15 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
87 schema:familyName Krupashankar
88 schema:givenName S.
89 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010131407614.15
90 rdf:type schema:Person
91 sg:person.010316745623.36 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
92 schema:familyName Radhakrishnan
93 schema:givenName Venkatraman
94 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010316745623.36
95 rdf:type schema:Person
96 sg:person.011770565440.24 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
97 schema:familyName Kalaiyarasi
98 schema:givenName Jayachandran Perumal
99 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011770565440.24
100 rdf:type schema:Person
101 sg:person.01225301441.63 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
102 schema:familyName Dhanushkodi
103 schema:givenName Manikandan
104 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225301441.63
105 rdf:type schema:Person
106 sg:person.013004716016.82 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
107 schema:familyName Mehra
108 schema:givenName Nikita
109 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013004716016.82
110 rdf:type schema:Person
111 sg:person.01354150255.82 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
112 schema:familyName Ganesan
113 schema:givenName Trivadi S.
114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354150255.82
115 rdf:type schema:Person
116 sg:person.015576370407.55 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
117 schema:familyName Sagar
118 schema:givenName Tenali Gnana
119 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015576370407.55
120 rdf:type schema:Person
121 sg:person.0657501276.96 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
122 schema:familyName Kannan
123 schema:givenName Krishnarathinam
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657501276.96
125 rdf:type schema:Person
126 sg:person.0716343050.48 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
127 schema:familyName Ganesan
128 schema:givenName Prasanth
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716343050.48
130 rdf:type schema:Person
131 https://app.dimensions.ai/details/publication/pub.1082058251 schema:CreativeWork
132 https://doi.org/10.1016/j.jhin.2016.04.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024916616
133 rdf:type schema:CreativeWork
134 https://doi.org/10.1016/s1658-3876(08)50023-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031018815
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1056/nejmoa0904544 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036718725
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1056/nejmoa1010222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030828053
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1111/ajco.12333 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040889000
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1111/bjh.13406 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017282100
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1155/2015/710543 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031328730
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1182/blood-2008-09-179341 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032016811
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1182/blood-2009-07-235358 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042177075
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1182/blood-2010-07-295279 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010761932
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1182/blood-2015-01-623447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049798638
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1182/blood-2015-07-657403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036230934
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1200/jco.2010.33.7303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036777863
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1200/jco.2012.47.4874 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034938389
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1200/jco.2013.48.6886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034141191
161 rdf:type schema:CreativeWork
162 https://www.grid.ac/institutes/grid.418600.b schema:alternateName Cancer Institute
163 schema:name Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India
164 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...